487 related articles for article (PubMed ID: 21430527)
1. Destination therapy with left ventricular assist devices: patient selection and outcomes.
Slaughter MS; Meyer AL; Birks EJ
Curr Opin Cardiol; 2011 May; 26(3):232-6. PubMed ID: 21430527
[TBL] [Abstract][Full Text] [Related]
2. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
[TBL] [Abstract][Full Text] [Related]
3. Patient selection for left ventricular assist devices.
Lund LH; Matthews J; Aaronson K
Eur J Heart Fail; 2010 May; 12(5):434-43. PubMed ID: 20172939
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
[TBL] [Abstract][Full Text] [Related]
5. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
Rogers JG; Bostic RR; Tong KB; Adamson R; Russo M; Slaughter MS
Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
[TBL] [Abstract][Full Text] [Related]
7. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
[TBL] [Abstract][Full Text] [Related]
9. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure.
Slaughter MS; Pagani FD; Rogers JG; Miller LW; Sun B; Russell SD; Starling RC; Chen L; Boyle AJ; Chillcott S; Adamson RM; Blood MS; Camacho MT; Idrissi KA; Petty M; Sobieski M; Wright S; Myers TJ; Farrar DJ;
J Heart Lung Transplant; 2010 Apr; 29(4 Suppl):S1-39. PubMed ID: 20181499
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular assist devices as destination therapy: a new look at survival.
Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
[TBL] [Abstract][Full Text] [Related]
11. Destination therapy: patient selection and current outcomes.
Lietz K
J Card Surg; 2010 Jul; 25(4):462-71. PubMed ID: 20529162
[TBL] [Abstract][Full Text] [Related]
12. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
[TBL] [Abstract][Full Text] [Related]
13. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
[TBL] [Abstract][Full Text] [Related]
14. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
Pagani FD; Miller LW; Russell SD; Aaronson KD; John R; Boyle AJ; Conte JV; Bogaev RC; MacGillivray TE; Naka Y; Mancini D; Massey HT; Chen L; Klodell CT; Aranda JM; Moazami N; Ewald GA; Farrar DJ; Frazier OH;
J Am Coll Cardiol; 2009 Jul; 54(4):312-21. PubMed ID: 19608028
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
[TBL] [Abstract][Full Text] [Related]
16. [Current success and risks of mechanichal circulatory support].
Menon AK
Anasthesiol Intensivmed Notfallmed Schmerzther; 2011 Jun; 46(6):434-41; quiz 442. PubMed ID: 21688233
[TBL] [Abstract][Full Text] [Related]
17. Implantation of the HeartWare left ventricular assist device.
Slaughter MS
Semin Thorac Cardiovasc Surg; 2011; 23(3):245-7. PubMed ID: 22172363
[TBL] [Abstract][Full Text] [Related]
18. Ventricular assist device therapy.
Sayer G; Naka Y; Jorde UP
Cardiovasc Ther; 2009; 27(2):140-50. PubMed ID: 19426251
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular assist devices.
Birks EJ
Heart; 2010 Jan; 96(1):63-71. PubMed ID: 19617213
[TBL] [Abstract][Full Text] [Related]
20. Cardiac extracorporeal life support: state of the art in 2007.
Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]